Jacobs Levy Equity Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Jacobs Levy Equity Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-183,459	Closed	-$2.52M	–	1037
2019 Q2	$2.52M	Sell	183,459 -4,570	-2%	-$69.9K	0.03%	485
2019 Q1	$3.24M	Buy	188,029 +58,400	+45%	+$924K	0.05%	409
2018 Q4	$1.66M	Buy	129,629 +22,124	+21%	+$336K	0.03%	501
2018 Q3	$1.75M	Sell	107,505 -10,649	-9%	-$152K	0.02%	545
2018 Q2	$1.52M	Buy	+118,154	New	+$1.6M	0.02%	557

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jacobs Levy Equity Management's OXFD Position: Q3 2019 in Review

Jacobs Levy Equity Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 183,459 shares — an estimated $2.52M sold.

Jacobs Levy Equity Management first reported a position in OXFD in Q2 2018 and held it in 5 quarters. The position peaked at $3.24M in Q1 2019. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

Jacobs Levy Equity Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 183,459 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $2.52M.
Jacobs Levy Equity Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2018 and held it in 5 quarters.
Jacobs Levy Equity Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.24M in Q1 2019.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2019, filed 14 Nov 2019.